Scholar Rock Holding (SRRK) Operating Expenses (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Operating Expenses of $102.0 million in Q1 2026, up 11.01% quarter-over-quarter from $91.9 million in Q4 2025, and up 32.33% on a YoY basis from $77.1 million in Q1 2025.

Scholar Rock Holding (SRRK) Operating Expenses (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Operating Expenses history runs 10 years deep, the most recent figure standing at $102.0 million for Q1 2026.

  • In Q1 2026, Operating Expenses rose 32.33% year-over-year to $102.0 million; the TTM figure through Mar 2026 stood at $409.6 million (up 51.29% YoY), while the FY2025 annual figure was $384.6 million, up 52.6% from the prior year.
  • Operating Expenses was $102.0 million for Q1 2026 at Scholar Rock Holding, up from $91.9 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $112.1 million in Q2 2025 to a low of $39.1 million in Q2 2023.
  • Historically, Operating Expenses has averaged $63.4 million across 5 years, with a median of $58.4 million in 2024.
  • The sharpest annual moves came in 2023 and 2025: Operating Expenses dropped 9.42% in 2023, then surged 88.42% in 2025.
  • A 5-year view of Operating Expenses shows it stood at $40.4 million in 2022, then advanced by 18.81% to $48.0 million in 2023, then surged by 44.4% to $69.4 million in 2024, then surged by 32.5% to $91.9 million in 2025, then climbed by 11.01% to $102.0 million in 2026.
  • The last three Operating Expenses figures came in at $102.0 million (Q1 2026), $91.9 million (Q4 2025), and $103.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 4.33 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 32.68 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 2.97 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn -138.30 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 15.76 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -3.82 Mn
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 574,669.00
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 1.85 Bn
9 Abivax 94.37 Bn 94.37 Bn - -67.40 Mn
10 Scholar Rock Holding 5.57 Bn 5.09 Bn - 102.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 102.02 Mn
Dec 31, 2025 91.90 Mn
Sep 30, 2025 103.55 Mn
Jun 30, 2025 112.11 Mn
Mar 31, 2025 77.09 Mn
Dec 31, 2024 69.36 Mn
Sep 30, 2024 64.78 Mn
Jun 30, 2024 59.50 Mn
Mar 31, 2024 58.42 Mn
Dec 31, 2023 48.03 Mn
Sep 30, 2023 43.67 Mn
Jun 30, 2023 39.08 Mn
Mar 31, 2023 40.51 Mn
Dec 31, 2022 40.43 Mn
Sep 30, 2022 43.86 Mn
Jun 30, 2022 43.15 Mn
Mar 31, 2022 40.13 Mn
Dec 31, 2021 39.41 Mn
Sep 30, 2021 42.54 Mn
Jun 30, 2021 34.87 Mn